Bioreactors Market Size

Bioreactors Market Size

Bioreactors Market size surpassed USD 8.5 billion in 2022 and is projected to expand at over 12% CAGR from 2023-2032.

To get key market trends

  Download Free Sample

A surge in the number of initiatives focusing on orphan drug development will have a positive impact on the bioreactors industry outlook. Over the last decade, scientific advances in the field of genetics and next-generation therapeutics such as the application of gene therapy and biomarkers have accelerated the demand for orphan therapies. The rapid proliferation of orphan therapies can be attributed to the growing need for the treatment of rare diseases and FDA approvals which validate and boost the sales of orphan drugs.

Growing concerns associated with extractables and leachables may impede the adoption of bioreactors. The use of disposable plastic bioreactors in the manufacturing of biopharmaceutical products poses a risk of contamination. The toxicology of plasticizers, slip agents, surface enhances, initiators, and monomers and the possible leaching of surface enhancers into the drugs could lead to adverse effects on patient health. Despite the wide range of benefits provided by single-use bioreactors, they may react unfavorably or fully neutralize biopharmaceuticals. This scenario negatively affects the adoption of bioreactors across biotech companies due to strict regulatory compliances monitoring biotech cell toxicity and human toxicology.